Capricor Therapeutics Inc (CAPR) concluded trading on Wednesday at a closing price of $20.51, with 2.79 million shares of worth about $57.25 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 269.55% during that period and on October 16, 2024 the price saw a loss of about -5.05%. Currently the company’s common shares owned by public are about 31.15M shares, out of which, 27.08M shares are available for trading.
Stock saw a price change of 18.49% in past 5 days and over the past one month there was a price change of 303.74%. Year-to-date (YTD), CAPR shares are showing a performance of 319.43% which increased to 620.91% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $2.68 but also hit the highest price of $23.40 during that period. The average intraday trading volume for Capricor Therapeutics Inc shares is 2.63 million. The stock is currently trading 40.39% above its 20-day simple moving average (SMA20), while that difference is up 143.30% for SMA50 and it goes to 246.35% higher than SMA200.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Capricor Therapeutics Inc (NASDAQ: CAPR) currently have 31.15M outstanding shares and institutions hold larger chunk of about 19.92% of that.
The stock has a current market capitalization of $667.40M and its 3Y-monthly beta is at 4.05. It has posted earnings per share of -$0.93 in the same period. It has Quick Ratio of 1.37 while making debt-to-equity ratio of 0.45. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for CAPR, volatility over the week remained 17.58% while standing at 20.08% over the month.
Stock’s fiscal year EPS is expected to drop by -47.71% while it is estimated to increase by 42.41% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Oppenheimer on May 17, 2024 offering an Outperform rating for the stock and assigned a target price of $14 to it. Coverage by Cantor Fitzgerald stated Capricor Therapeutics Inc (CAPR) stock as an Overweight in their note to investors on January 05, 2024, suggesting a price target of $8 for the stock. Stock get a Buy rating from H.C. Wainwright on January 26, 2018.
